093_SB0060
LRB093 02170 ACG 02177 b
1 AN ACT concerning the health care.
2 Be it enacted by the People of the State of Illinois,
3 represented in the General Assembly:
4 Section 5. The Illinois Health Finance Reform Act is
5 amended by changing Section 4-2 as follows:
6 (20 ILCS 2215/4-2) (from Ch. 111 1/2, par. 6504-2)
7 Sec. 4-2. Powers and duties.
8 (a) (Blank).
9 (b) (Blank).
10 (c) (Blank).
11 (d) Uniform Provider Utilization and Charge Information.
12 (1) The Department of Public Health shall require
13 that hospitals licensed to operate in the State of
14 Illinois adopt a uniform system for submitting patient
15 charges for payment from public and private payors
16 effective January 1, 1985. This system shall be based
17 upon adoption of the uniform hospital billing form
18 (UB-92) or its successor form developed by the National
19 Uniform Billing Committee.
20 (2) (Blank).
21 (3) The Department of Insurance shall require all
22 third-party payors, including but not limited to,
23 licensed insurers, medical and hospital service
24 corporations, health maintenance organizations, and
25 self-funded employee health plans, to accept the uniform
26 billing form, without attachment as submitted by
27 hospitals pursuant to paragraph (1) of subsection (d)
28 above, effective January 1, 1985; provided, however,
29 nothing shall prevent all such third party payors from
30 requesting additional information necessary to determine
31 eligibility for benefits or liability for reimbursement
-2- LRB093 02170 ACG 02177 b
1 for services provided.
2 (e) (Blank).
3 (f) The Department of Public Health shall require any
4 pharmaceutical company that provides prescription drugs in
5 Illinois to disclose to the Department, in a manner and
6 fashion designated by the Department by rule, all
7 prescription drug advertising and promotion costs. The
8 Department must then conduct a cost/benefit analysis to
9 determine (i) the impact of these costs on prescription drug
10 prices and (ii) the impact on Illinois residents of any
11 increase of the prices and costs of prescription drugs that
12 is attributable to the advertising and promotional
13 activities.
14 (Source: P.A. 91-756, eff. 6-2-00; 92-597, eff. 7-1-02.)